Average Co-Inventor Count = 5.43
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (37 from 4,177 patents)
2. Abbvie Inc. (13 from 822 patents)
3. Galapagos Nv (9 from 116 patents)
4. Abbvie S.a.r.l. (9 from 15 patents)
5. Abbvie Bahamas Limited (6 patents)
6. Abbvie Overseas Sarl (5 patents)
59 patents:
1. 10647717 - N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
2. 10604515 - Heteroaryl substituted pyridines and methods of use
3. 10508113 - Inhibitors of tyrosine kinase 2 mediated signaling
4. 10259810 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
5. 10138227 - Heteroaryl substituted pyridines and methods of use
6. 10130622 - Compounds for treatment of cystic fibrosis
7. 10047051 - Substituted pyridines and method of use
8. 9969693 - 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use
9. 9890158 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
10. 9840513 - Substituted tricyclics and method of use
11. 9796711 - [object Object]
12. 9777020 - Furo-3-carboxamide derivatives and methods of use
13. 9452986 - 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use
14. 9186353 - Treatment of osteoarthritis pain
15. 9181275 - Mercaptoamidine derivatives and methods of use